News & Events about Day One Biopharmaceuticals I.
Thinking about buying stock in Duck Creek Technologies, CureVac, Day One Biopharmaceuticals, Bed Bath & Beyond, or Ocugen? Thinking about buying stock in Duck Creek Technologies, CureVac, Day One Biopharmaceuticals, Bed Bath & Beyond, or Ocugen? PR Newswire NEW YORK, Jan. 9, 2023...
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN Get Rating) has earned an average recommendation of Buy from the six analysts that are presently covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price objective ...
SOUTH SAN FRANCISCO, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that Dr. Jeremy ...
Globe Newswire
2 months ago
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2022 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced two upcoming ...
The Allen Institute appointed Chris Beaudoin as its new chief operations officer. Beaudoin was previously chief operating officer at Swedish, a Seattle-area healthcare system affiliated with Providence. Prior to joining Swedish, Beaudoin spent a decade at Renton-based Providence, working in pharmacy...